Rejuvenating immunity: “anti-aging drug today” eight years later

The 2014 year ended with celebration: Everolimus, a rapamycin analog, was shown to improve immunity in old humans, heralding ‘a turning point’ in research and new era in human quest for immortality. Yet, this turning point was predicted a decade ago. But what will cause human death, when aging will...

Descripción completa

Detalles Bibliográficos
Autor principal: Blagosklonny, Mikhail V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637294/
https://www.ncbi.nlm.nih.gov/pubmed/25844603
_version_ 1782399782173540352
author Blagosklonny, Mikhail V.
author_facet Blagosklonny, Mikhail V.
author_sort Blagosklonny, Mikhail V.
collection PubMed
description The 2014 year ended with celebration: Everolimus, a rapamycin analog, was shown to improve immunity in old humans, heralding ‘a turning point’ in research and new era in human quest for immortality. Yet, this turning point was predicted a decade ago. But what will cause human death, when aging will be abolished?
format Online
Article
Text
id pubmed-4637294
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-46372942015-12-02 Rejuvenating immunity: “anti-aging drug today” eight years later Blagosklonny, Mikhail V. Oncotarget Research Perspective The 2014 year ended with celebration: Everolimus, a rapamycin analog, was shown to improve immunity in old humans, heralding ‘a turning point’ in research and new era in human quest for immortality. Yet, this turning point was predicted a decade ago. But what will cause human death, when aging will be abolished? Impact Journals LLC 2015-03-31 /pmc/articles/PMC4637294/ /pubmed/25844603 Text en Copyright: © 2015 Blagosklonny http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Perspective
Blagosklonny, Mikhail V.
Rejuvenating immunity: “anti-aging drug today” eight years later
title Rejuvenating immunity: “anti-aging drug today” eight years later
title_full Rejuvenating immunity: “anti-aging drug today” eight years later
title_fullStr Rejuvenating immunity: “anti-aging drug today” eight years later
title_full_unstemmed Rejuvenating immunity: “anti-aging drug today” eight years later
title_short Rejuvenating immunity: “anti-aging drug today” eight years later
title_sort rejuvenating immunity: “anti-aging drug today” eight years later
topic Research Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637294/
https://www.ncbi.nlm.nih.gov/pubmed/25844603
work_keys_str_mv AT blagosklonnymikhailv rejuvenatingimmunityantiagingdrugtodayeightyearslater

Ejemplares similares